A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 10,792 shares of EXAS stock, worth $480,999. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,792
Previous 10,966 1.59%
Holding current value
$480,999
Previous $811,000 8.14%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$56.27 - $73.77 $9,790 - $12,835
-174 Reduced 1.59%
10,792 $745,000
Q4 2023

Feb 07, 2024

BUY
$59.06 - $75.72 $3,543 - $4,543
60 Added 0.55%
10,966 $811,000
Q3 2023

Nov 08, 2023

SELL
$65.94 - $99.04 $3,099 - $4,654
-47 Reduced 0.43%
10,906 $744,000
Q2 2023

Jul 28, 2023

SELL
$62.68 - $95.05 $13,664 - $20,720
-218 Reduced 1.95%
10,953 $1.03 Million
Q1 2023

May 10, 2023

SELL
$47.19 - $70.77 $482,376 - $723,410
-10,222 Reduced 47.78%
11,171 $757,000
Q4 2022

Feb 10, 2023

SELL
$30.35 - $53.15 $29,469 - $51,608
-971 Reduced 4.34%
21,393 $1.06 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $483,674 - $746,918
15,129 Added 209.11%
22,364 $727,000
Q2 2022

Aug 09, 2022

BUY
$35.61 - $76.23 $69,795 - $149,410
1,960 Added 37.16%
7,235 $285,000
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $103,895 - $148,984
1,805 Added 52.02%
5,275 $369,000
Q4 2021

Feb 23, 2022

BUY
$72.5 - $100.68 $86,637 - $120,312
1,195 Added 52.53%
3,470 $270,000
Q3 2021

Nov 09, 2021

SELL
$90.24 - $124.05 $30,049 - $41,308
-333 Reduced 12.77%
2,275 $217,000
Q2 2021

Aug 11, 2021

BUY
$93.66 - $139.27 $17,420 - $25,904
186 Added 7.68%
2,608 $324,000
Q1 2021

Apr 28, 2021

BUY
$116.57 - $155.01 $72,506 - $96,416
622 Added 34.56%
2,422 $319,000
Q4 2020

Jan 20, 2021

BUY
$99.61 - $142.12 $179,298 - $255,816
1,800 New
1,800 $238,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.89B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.